Clinical and Functional Assessment of Patients With Transfemoral Amputation Treated With Osteointegrated Implant
OSTEO-OUTCOME
1 other identifier
interventional
15
1 country
1
Brief Summary
Limb amputation is a traumatic event that significantly reduces the ability to perform daily activities, impairs mobility, and lowers quality of life. In Italy, approximately 4 million people live with disabilities, with 1.2 million having motor disabilities. Among lower limb amputees (around 200,000), most are elderly, with amputations due to diabetic or vascular issues. Other groups include middle-aged adults (often victims of workplace accidents) and young individuals (victims of traffic accidents). Post-amputation rehabilitation mainly involves the use of prostheses, which, however, can cause skin problems due to the socket (the part that anchors the prosthesis to the residual limb). Among patients using a socket, 34-63% develop chronic skin issues and pain. Complications include excessive sweating, sores, abscesses, and irritation. Additionally, daily volume changes in the residual limb and long-term weight fluctuations further complicate the use of conventional prostheses. In the last two decades, research groups, assisted by experienced surgeons, have worked to develop implant solutions that bypass the socket and address these issues. One such solution is osteointegrated prostheses, which use the principle of osteointegration to anchor the prosthesis directly to the bone of the residual limb. A metal stem is surgically inserted into the medullary canal of the residual limb and fixed through bone growth, establishing a direct connection between the amputated limb and the external prosthesis. Osteointegrated prostheses are widely accepted worldwide as a valid alternative to socket prostheses, especially for young and active individuals with transfemoral, transtibial, transhumeral, or transradial amputations not caused by vascular issues. The key benefit of osteointegration is the restoration of load alignment along the anatomical and mechanical axis, improving control of the residual limb during walking, as well as overall functional capacity and quality of life. Other advantages include greater stability, enhanced sitting comfort, a wider range of hip movement, faster attachment and detachment of the prosthesis, and improved body perception. Additionally, the direct contact between the metal stem and the bone generates sensory feedback (osteoperception), allowing the patient to better control the amputated limb by perceiving ground contact through vibrations transmitted to the bone. Osteointegration offers the only viable alternative for prosthetic use in patients with a short residual limb, where conventional socket prostheses would not be suitable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2024
CompletedFirst Posted
Study publicly available on registry
December 17, 2024
CompletedStudy Start
First participant enrolled
January 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
February 17, 2026
February 1, 2026
1.7 years
December 11, 2024
February 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EQ-5D-5L
It is a generic tool for measuring perceived quality of life in relation to health status, divided into 5 domains, each assigned a score ranging from 1 (best possible outcome) to 5 (worst possible outcome): mobility, self-care, daily activities, pain/discomfort, and anxiety/depression. Additionally, there is a domain related to general health, scored from 0 (worst possible health status) to 100 (best possible health status)
12 months after surgery
Secondary Outcomes (6)
Q-TFA
12 months after surgery
VAS
12 months after surgery
ABIS
12 months after surgery
TAPES
12 months after surgery
PWB-PTCQ
12 months after surgery
- +1 more secondary outcomes
Study Arms (1)
patients undergoing osseointegration surgery for transfemoral amputation
EXPERIMENTALInterventions
osseointegrated surgery for transfemoral amputation
Eligibility Criteria
You may qualify if:
- Subjects of both sexes, aged between 18 and 65 years;
- Subjects with unilateral transfemoral amputation, following trauma, tumor, infection, or congenital defect;
- Subjects already scheduled for osteointegrated prosthesis surgery for amputation;
- BMI \< 35 kg/m²;
- Difficulty in using the traditional socket prosthesis (pain, reduced mobility, short residual limb, skin infections, ulcers, volume changes in the residual limb);
- Subjects who have signed informed consent and reviewed the study information sheet.
You may not qualify if:
- Peripheral vascular diseases;
- Pregnancy;
- Rheumatoid arthritis;
- Neurological deficits;
- Amputation of the contralateral limb;
- Active infections;
- Immunodeficiency;
- Comorbidities/concurrent disabilities, general or localized (Multiple Sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.), that may interfere with the study;
- Presence of uncontrolled psychiatric comorbidities;
- Declared or evident cognitive deficits that would impair understanding of the tasks required (MMSE ≤ 24);
- Insufficient degree of cooperation;
- Length of the bone stump (measured from the lesser trochanter to the apex of the stump) less than 15 cm;
- Previous radiotherapy on the amputated limb;
- Ongoing chemotherapy treatments.
- Smoking;
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Rizzoli Orthopedic Institute
Bologna, 40136, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor Medicine and Surgery, University of Bologna
Study Record Dates
First Submitted
December 11, 2024
First Posted
December 17, 2024
Study Start
January 31, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
February 17, 2026
Record last verified: 2026-02